Larotrectinib in adult patients with solid tumours: a multi-centre, open-label, phase I dose-escalation study

2019152 citationsJournal Articlebronze Open Access

Authors

Good health and well-being

Published in: Annals of Oncology

Volume 30, Issue 2, pp. 325-331

Field-Weighted Citation Impact: 15.63